[Study on degradation kinetics or potassium dehydroandrographolidi succinas]
Wei-wei Luo1, Ying-ju He, Ling Wang
1Department of Pharmaceutical Sciences, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
Summary
Potassium Dehydroandrographolidi Succinas (DAS-K) degrades via first-order kinetics in aqueous solutions. Its hydrolytic degradation rate is significantly influenced by pH, temperature, and buffer composition, with alkaline pH accelerating decomposition.
Area of Science:
- Pharmaceutical Chemistry
- Chemical Kinetics
- Analytical Chemistry
Background:
- Potassium Dehydroandrographolidi Succinas (DAS-K) is a compound requiring stability assessment.
- Understanding hydrolytic degradation is crucial for drug formulation and shelf-life determination.
Purpose of the Study:
- To investigate the hydrolytic degradation kinetics of DAS-K in aqueous solutions.
- To identify key factors influencing DAS-K stability.
Main Methods:
- High-Performance Liquid Chromatography (HPLC) was employed to monitor DAS-K degradation.
- Kinetic parameters were determined under varying conditions: initial concentration, pH, ionic strength, temperature, and buffer types.
Main Results:
- DAS-K hydrolysis followed first-order kinetics.
- Degradation rate increased significantly with pH, indicating instability in alkaline conditions.
- Temperature dependence was substantial, with an activation energy of 95.68 KJ/mol at pH 8 in phosphate buffer.
- Buffer species impacted the catalytic degradation process, while ionic strength had minimal effect.
Conclusions:
- Hydrolytic degradation of DAS-K adheres to first-order kinetics.
- Solution pH is a critical determinant of DAS-K degradation rate.
- Buffer concentration, buffer species, and temperature also influence the drug's stability.
Related Concept Videos
01:17Kinetics of Drug Elimination
Eliminating drugs from the body is a vital process that occurs through excretion or metabolism. Understanding the kinetics of drug elimination is crucial for drug development, dosage determination, and optimizing patient outcomes.
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
02:21Oxidation of Alkenes: Syn Dihydroxylation with Potassium Permanganate
Alkenes can be dihydroxylated using potassium permanganate. The method encompasses the reaction of an alkene with a cold, dilute solution of potassium permanganate under basic conditions to form a cis-diol along with a brown precipitate of manganese dioxide.
01:14Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
01:19Depolarizing Blockers: Pharmocokinetics
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
01:21Toxicokinetics: Overview
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
01:30Measurement of Bioavailability: Pharmacokinetic Methods
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...